American singer and songwriter Kelly Clarkson recently shared insights into her weight loss journey during an episode of her talk show. Speaking with Whoopi Goldberg on “The Kelly Clarkson Show,” she revealed that contrary to speculation, she did not rely on the well-known drug Ozempic. Rather, the medication she used was prescribed by her physician.
Clarkson’s weight loss has been a subject of interest among fans for some time. Her dramatic transformation has sparked curiosity about how the 42-year-old achieved it. Many speculated that she might have turned to weight loss drugs for assistance. However, Clarkson clarified during the latest episode of her show that while she did utilize a weight loss medication, it was not Ozempic, as commonly assumed.
During her conversation with Goldberg, Clarkson explained that her doctor had prescribed the medication to assist with her weight loss efforts. She also addressed the misconception surrounding Ozempic, emphasizing that her chosen medication was different.
Notably, Clarkson revealed that the medication she took aided her body in processing sugar intake. She shared,
“For two years, my doctor was encouraging me to try it, but I was hesitant due to existing thyroid issues. Despite the assumptions, it wasn’t Ozempic. It’s something else entirely… I don’t use Ozempic.”
Additionally, Clarkson took a moment during the show to engage in a warm exchange with Goldberg, complimenting her youthful appearance:
“Every time I see you, you seem to defy aging! You’re like Benjamin Button. It’s remarkable every time you enter the room!”
In response, Goldberg acknowledged her use of a beneficial treatment, stating:
“I’m utilizing that fantastic shot that’s been helpful for those in need, and it’s been quite beneficial for me.”
Clarkson, meanwhile, reiterated that she did not opt for the FDA-approved drug, clarifying:
“I don’t use Ozempic.”
The post Kelly Clarkson Opens Up About Her Weight Loss on Talk Show first appeared on YouthSpeaks - Latest News About Business, Technology and More..
